Orbit Genomics
Boulder, Colorado, United States · Biotechnology · 9 employees
Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through early warning genomics. Our patent pending OrbiSeq™ platform analyzes novel genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. OrbiSeq can be applied to diagnose, treat and help prevent complex diseases inclu
Funding history
- Series seed — $780K — Jul 2025
- Series seed — $780K — Mar 2025
Recent signals
- Jul 28, 2025: Raised $780K in Series seed
- Mar 18, 2025: Raised $780K in Series seed
See plans & pricing → Track Orbit Genomics’s funding, hiring, and signals — with verified contacts — on Fundz.